KhanhC.Hoang

Gene Therapy is a high risk high reward

Long
KhanhC.Hoang Aggiornato   
NASDAQ:SELB   None
back in Oct 2020 -> "an early Moderna (MRNA) investor and Harvard PhD, Timothy Springer, continued to pour his fortune into this small cap stock. Mr. Springer also happens to be a director at Selecta Biosciences. He reportedly purchased more than 6,500,000 shares in October. He went on a shopping spree on October 7 when he bought 654,953 shares at $1.65 and continued buying all the way to October 23 when he bought 994,448 shares for $2.71."
Commento:
daily chart for the initial entry

Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.